Latest News

Promising arm 1 results from MiST trial to be presented at ASCO meeting

Initial results from arm, using rucaparib to treat mesothelioma in relapsed patients, indicates promising efficacy.

Support for researchers during the COVID-19 pandemic

We want to be sure that researchers supported by the Asthma UK and British Lung Foundation Partnership are safe.

Results of MRN annual survey

96% of survey respondents would recommend being an MRN member to a colleague.

Need high-quality patient material for your studies? Contact MesobanK!

MesobanK provides high-quality samples from people with mesothelioma and accompanying data for research studies.